Will be looking for pennant continuation move post 3050 in the case of Adani Green.

No trigger yet. The chart is still strong

More from The_Chartist 📈

$The_Chartist \U0001f4c8$

The_Chartist 📈...
@nison_steve

CDSL - First target achieved. ✅

On to the next target of 1780.

Updated chart. https://t.co/Ux4GVGnWp8

CDSL - Targets opened

1575 & 1780

Weak below 1360 pic.twitter.com/0dorwkzVOK
— The_Chartist \U0001f4c8 (@nison_steve) November 4, 2021

Steve Nison
@nison_steve

SAIL - I am not holding it as of now. Chart for learning purposes. I always have a bullish bias for a stock in a particular sector that is performing so well.

A typical example of stock taking a pause in between during its upwards journey.

Steve Nison
@nison_steve

Laurus Labs - Double top buy will be activated above closing of 690. Target still active: 895 (1%*3 box size and reversal)

✅✅ https://t.co/MtJOLfpzYj

Laurus Labs - I am waiting till 3:15 PM to get confirmation of closing above 700 to add more of it in my portfolio. \u2705\u2705 pic.twitter.com/UxZCuxhuIX
— Steve Nison (@nison_steve) August 9, 2021

$The_Chartist \U0001f4c8$

The_Chartist 📈...
@charts_zone

Target open for Asian Paints is 2700 https://t.co/FXKaJEeOoT

Turn by turn the leaders crack.

Asian Paints https://t.co/2e5pm2DTdg pic.twitter.com/esIhvhXT37
— The_Chartist \U0001f4c8 (@charts_zone) May 25, 2022

$The_Chartist \U0001f4c8$

The_Chartist 📈...
@charts_zone

H&S tops with ascending/descending necklines https://t.co/cmRRHp5rlh

Sir Edwards & Magee discussed sloping necklines in H&S in their classical work. I am considering this breakdown by Affle as an H&S top breakdown with a target open of 770.

The target also coincides with support at the exact same level. pic.twitter.com/n84kSgkg4q
— The_Chartist \U0001f4c8 (@charts_zone) May 25, 2022

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice

1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021

@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2

1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021

@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o